As a postdoc in Rick Helmich's research group, you will use cutting-edge neuroimaging and neuromodulation techniques to investigate how the clinical phenotype of Parkinson's disease (PD) is shaped by longitudinal changes in compensatory brain mechanisms. This position aims to alleviate PD symptoms by enhancing brain compensation using modern non-invasive neuromodulation technology (low-intensity transcranial ultrasound sonification [TUS]. On this topic, we currently offer two postdoctoral researcher positions. This vacancy is for position 2. Position 1 aims to develop new biomarkers of brain compensation based on resting-state functional MRI. You are welcome to apply for both positions. In that case, it is sufficient to apply for 1 vacancy and clearly indicate in your letter that you are applying for both vacancies.
Background PD is a common, debilitating neurodegenerative condition characterized by motor and non-motor symptoms that worsen over time. The pathological hallmark of PD, progressive cell loss in the nigro-striatal dopaminergic system, cannot fully account for this worsening, suggesting that the clinical course of PD must be determined by additional brain mechanisms. In support of this, we recently demonstrated that the clinical phenotype of PD depends on the integrity of compensatory mechanisms located in parietal and premotor areas of the cerebral cortex.
This raises exciting questions about how cortical compensation changes over time, how these changes influence the progression of symptoms, and whether they can be targeted to manipulate the clinical course of PD. The aim of this project is to better understand the role that compensatory mechanisms play in shaping the clinical progression of PD. In pursuit of this aim, we offer two postdoctoral researcher positions that focus on different aspects of compensation: quantification and manipulation.
Position This position is funded by ParkinsonNL and will focus on evaluating whether brain compensation can be enhanced through non-invasive neuromodulation, and whether such enhancement contributes to clinical improvement. To achieve this, you will set up a trial where 30 PD patients undergo low-intensity TUS, applied separately to the dorsal premotor cortex and the putamen.
The TUS protocol will be preceded and followed by a task-based functional MRI protocol designed to quantify cortical compensation and basal ganglia dysfunction, enabling you to determine the cerebral effects of TUS, which can then be linked to clinically beneficial effects captured by behavioral performance.
In Nijmegen, you will be embedded in the research group of Dr. Rick Helmich at the Donders Institute, Centre for Cognitive Neuroimaging. In addition, you will collaborate with the research group of Dr. Lennart Verhagen at the Donders Institute, Centre for Cognition, who is spearheading the establishment of TUS as a viable neuromodulation method within the Netherlands.
Tasks - Set up the trial, complete the IRB process, recruit 30 PD patients, collect data.
- Determine effects of TUS on brain indices of compensation and pathology (including fMRI), and on behavioral performance.
- Develop new scientific approaches to determine intervention effects on brain compensation and pathology in PD patients.